Lauren Willard is an Endocrinology/Metabolic physician affiliated with University of Pittsburgh Medical Center. OpenAlex indexes 9 publications with 316 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Locust St
Suite 5120
Pittsburgh, PA 152195114
Telephone
412-586-9700Registry record last updated 24 Jun 2014.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20253 payments
- Amgen Inc.Program year20242 payments
- Amgen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
66.9%Insulin Analog23.6%Lantus Solostar44%Humalog Kwikpen U-10020%Basaglar Kwikpen U-10010%Novolog Flexpen6%Tresiba Flextouch U-1006%Insulin Aspart Flexpen6%Toujeo Max Solostar5%Tresiba Flextouch U-2005%Part D<11 patientsGLP-1 receptor agonist22.3%Ozempic46%Mounjaro41%Trulicity13%Part D≥20 patients+ 5 more classes in this area
Hormonal (systemic)
19.8%l-Thyroxine18.7%Levothyroxine Sodium80%Synthroid20%Part D≥49 patientsParathyroid Hormone Analog1%Teriparatide100%Part D<11 patientsCardiovascular
9.8%Statin4.3%Rosuvastatin Calcium59%Atorvastatin Calcium42%Part D<11 patientsACE inhibitor2.1%Lisinopril100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 6574 Pheochromocytoma In A Patient With ESRD; Clinical Challenges And Lessons From A Successful Evaluation
Journal of the Endocrine Society
2024 - Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS)
BMJ Open Diabetes Research & Care
2016 - Efficacy and Safety of Continuous Insulin Infusion Protocols With Glycemic Targets of 110-140 mg/dL in Patients With and Without Diabetes Following Cardiac Surgery
Journal of Diabetes Science and Technology
2014 - Comparison of Insulin Infusion Protocols Targeting 110–140 mg/dL in Patients After Cardiac Surgery
Diabetes Technology & Therapeutics
2012 - Two Post-Cardiac Surgery IV Insulin Protocols Targeting Blood Glucose 110-1140mg/dL in Patients With and Without Diabetes2012
Similar KOLs
Other experts from the same institution or the same specialty.
Mubashir Mumtaz, MD
University of Pittsburgh Medical Center
Chadi Hage, MD
University of Pittsburgh Medical Center
Matthew Schuchert
University of Pittsburgh Medical Center
Seungwon Kim
University of Pittsburgh Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”